Sandbox Reserved 1502: Difference between revisions

From Proteopedia
Jump to navigationJump to search
No edit summary
No edit summary
Line 45: Line 45:
The new experimental antirviral, here the (6-chloro-2-oxo-4-phenyl-1,2-dihydroquinolin-3-yl)acetic acid, interacts with the site with which <scene name='80/802676/Site_of_interaction/7'>the cofactor bind with the LEDGF/p75 cofactor</scene>. This site is situated in the core domain.
The new experimental antirviral, here the (6-chloro-2-oxo-4-phenyl-1,2-dihydroquinolin-3-yl)acetic acid, interacts with the site with which <scene name='80/802676/Site_of_interaction/7'>the cofactor bind with the LEDGF/p75 cofactor</scene>. This site is situated in the core domain.
The molecule then inhibits the interaction between the LEDGF/p75 cofactor and the integrase.
The molecule then inhibits the interaction between the LEDGF/p75 cofactor and the integrase.
The whole complex between the integrase and the cofactor is displyed on the proteopedia page [[2b4j]].
The whole complex between the integrase and the cofactor is displayed on the proteopedia page [[2b4j]].




Line 59: Line 59:


<scene name='80/802676/Hiv_integrase_3lpt/8'>HIV Integrase 3lpt</scene>
<scene name='80/802676/Hiv_integrase_3lpt/8'>HIV Integrase 3lpt</scene>
==See also==
http://proteopedia.org/wiki/index.php/2b4j :integrase ligated with the cofactor LEDGF/p75
== References ==
== References ==
https://www.hiv.gov/hiv-basics/overview/about-hiv-and-aids/what-are-hiv-and-aids
https://www.hiv.gov/hiv-basics/overview/about-hiv-and-aids/what-are-hiv-and-aids